Objective: To compare effects of a high carbohydrate (high-CHO) and a monounsaturated fat diet (high-MUFA) on body fat distribution and sex hormones in post-menopausal women with Type 2 diabetes. Design: Randomised cross-over with no washout. Setting: Geelong Hospital outpatient. Subjects: Thirty four women were recruited, 30 completed the study, and data are presented for 21 women compliant to the high-CHO diet.
Introduction
Diet plays an important role in the treatment of Type 2 diabetes. Current recommendations are either for a diet in which saturated fat is replaced by complex carbohydrate (low fat, high carbohydrate diet (high-CHO diet)) (American Diabetes Association, 1994) or by monounsaturated fat (`modi®ed fat' or high monounsaturated fat diet (MUFAdiet)) (American Diabetes Association, 1994; Garg, 1994) . The high-MUFA diet has a positive impact on metabolic control and other bene®ts on cardiovascular risk factors including improved 24 h blood pressure (Rassmussen et al, 1993; Garg et al, 1994; Campbell et al, 1994) . Moreover, although it is of high fat content, in a clinical setting it appears no more likely than a high-CHO diet to produce weight gain (reviewed in Garg, 1994) , and con®rmed also in our own study (Walker et al, 1995) . In contrast, high-CHO diets may adversely affect glycemic control and lipid levels (Riccardi & Rivellese, 1991; Garg et al, 1994) unless the carbohydrate consumed is also rich in dietary ®bre (Riccardi & Rivellese 1991) .
We have reported that when high-CHO diets are given to people with Type 2 diabetes, fat may be lost disproportionately from the lower body (hips and legs) rather than from the upper body (trunk), increasing the upper body to lower body fat ratio (Walker et al, 1996) . As this was a novel ®nding, we sought to repeat the study in a group of diabetic post-menopausal women in whom sex hormone changes were also measured. A more android pattern of adiposity in post-menopausal women (Ley et al, 1992) and women with Type 2 diabetes (Kissebah et al, 1982) is associated with increased risk of heart disease (Lapidus et al, 1984; Freedman et al, 1995) and also with a more androgenic hormone status (Haffner et al, 1991; Anderson et al, 1994) . We investigated the possibility that women adhering to a high-CHO weight reducing diet would exhibit changes in steroid hormone pro®le that differed from those found after a high-MUFA diet, in association with the different patterns of regional adipose tissue loss.
Research design and methods

Subjects
Thirty postmenopausal women with Type 2 diabetes were initially recruited to the study, which was approved by the Ethics Committees of Geelong Hospital and Deakin University. All women gave written informed consent. Twenty-one women were judged to have complied with the diets on the basis of the change in their plasma cholesteryl ester fatty acid composition in response to the high-CHO diet (see below). The data for these women is presented in what follows. They were aged 58 AE 7 y, (mean AE s.d.), had a mean body mass index (BMI) of 29.1 AE 0.7 kgam 2 , mean HbA 1c of 6.8 AE 1.4% and had been diagnosed with diabetes for 3 AE 3 y. Ten were treated with diet alone and 11 received oral hypoglycemic medication (glibenclamide (2), metformin (6), glicazide (4) tolbutamide (1)). Nine women were taking anti-hypertensive agents, three were on hypolipidemic drugs. Prescribed medication was taken throughout the study. None of the women were currently taking, or had previously received, hormone replacement therapy.
Experimental protocol A randomised cross-over design study was conducted on an outpatient basis. After a 12-week baseline period when women followed their habitual diet, 9 women commenced a high-CHO diet and 12 women commenced a high-MUFA diet, each followed for 12 weeks. After a four week break, the women followed the alternative diet for 12 weeks. The energy content of prescribed diets was determined individually for each woman based on predicted basal metabolic rate (BMR) calculated from sex, age and body weight, an activity factor and an energy de®cit of 2.1 MJad for weight loss (Nutrition Committee of the National Health and Medical Research Council, 1990) . For each woman, test diets were isocaloric. Usual physical activity patterns were maintained. Body weight, height, and a dual-energy X-ray absorptiometry (DXA) total body scan were taken at baseline and before and after the diets, when fatty acid composition of cholesteryl esters, HbA 1c , fasting glucose and insulin, lipoproteins and sex hormones were also measured.
Dietary interventions
The prescribed high-CHO diet provided 60% energy as ®bre-rich CHO and 20% as fat (7% total energy as MUFA); the prescribed high-MUFA diet provided 40% energy as CHO and 40% as fat (20% total energy as MUFA). In the MUFA diet sources of saturated fat were reduced and exchanged with MUFA, the main source of which was olive oil (Bertolli, Lucca, Italy). Butter and table or polyunsaturated margarines were not allowed, but up to 6% energy was supplied as an olive-oil based margarine (Walker et al, 1995) . In addition 5 ± 7 olives or 10 ± 20 g raw nuts, or 30 ± 60 g avocado were prescribed daily. The high-CHO diet was restricted in total fat intake and enriched by wholemeal or wholegrain bread, potatoes, rice and pasta and with whole grain breakfast cereals. This diet had a prescription for a ®bre intake of 4.8 gaMJ.
Subjects were given food scales and detailed instructions from a dietitian for recording dietary intake. They completed three seven-day weighed food records (1amonth) during the baseline period, and during each of the two diets. ). Whole body DXA scans (DPX-L; Lunar Corporation, Madison, WI) taken at a similar time in the early morning, were used to measure body composition. All subsequent scans were taken at the same settings as the initial scan as described previously (Walker et al, 1996) . In addition to total fat mass (FM), regional fat content in the upper and lower body (Ley et al, 1992) was determined as in our earlier study (Walker et al, 1996) . The upper border of the upper body was demarcated by a horizontal line passed under the jaw and by lateral lines passed obliquely through the shoulder joints; the lower border was demarcated by two oblique lines passing through the hip joints; and sides extended laterally to cover all soft tissue. The lower body (hips and legs) was the area below the lower border of the upper body. DXA measurement precision (coef®cient of variation (CV) obtained from ®ve subjects measured on ®ve separate occasions within a two week period) was 2.0% for total body FM, 3.7% for upper body fat and 3.8% for lower body fat.
Biochemical analyses
Before and after each dietary period, venous blood was collected after an overnight fast. Lipids were extracted from plasma cholesteryl esters and analysed for fatty acid content as described previously (Walker et al, 1996) . HbA 1c was estimated by ion-exchange chromatography. Glucose, triglyceride, total cholesterol and high density lipoprotein (HDL)-cholesterol (after separation with polyethylene glycol (Walker et al, 1995) were determined by automated enzymatic methods. The intrassayainterassay CV for these assays was 2.8a3.1%, 1.0a1.9%, 0.5a3.1% and 1.6a4.7%, respectively. Insulin, total testosterone, SHBG, and dehydroepiandrostrone sulphate (DHEAS) concentrations in serum were measured by radioimmunoassay. (Insulin: Linco Research Inc, St Charles, MO, CV 2.4a3.2%; total testosterone and SHBG: Orion Diagnostica, Espoo, Finland, CVs 2.9a2.7% and 2.7a3.9% respectively; dehydroepiandrostrone sulfate (DHEAS): ICN Biomedicals, Costa Mesa. CA, USA, CV 6.3a7.3%). In addition, oestrone, found at higher concentrations in serum of postmenopausal women than oestrogen, was also measured by radioimmunoassay (dc-Diagnostics Biochemic Canada Inc, London, Canada; Cas 10.2a14.7%) (The free androgen index (FAI) was determined as (testosteroneaSHBG)6100).
Statistical analyses
Data are expressed as the mean AE standard deviation. Nutrient intakes on the high-CHO and high-MUFA diets were compared by Student's paired t-test. This test was also used for before diet and after diet comparisons for individual parameters. Differences between the two arms of the cross-over study were evaluated using a general linear model for cross-over designs as discussed in Fleiss Diet and regional body fat distribution KZ Walker et al (1986) . Brie¯y, the difference between`before' and`after' diet measurements was used as the dependent variable. In addition to diet and sequence of diets, individual (or person) difference was also treated as an independent factor in the computations to derive an appropriate estimate of random error. The relationship between lower body fat and DHEAS concentration was determined by partial correlation analysis, controlling for the effect of age. Analyses were performed with the statistical software package SPSS for Windows 6.0 (SPSS Inc, Chicago). A P-value of less than 0.05 was considered statistically signi®cant.
Results
Dietary compliance
The fatty acid composition of cholesteryl esters in plasma was determined at the beginning and end of each test diet. In nine of the 30 women who completed the study, the proportion of linoleic acid (C18:2) in plasma cholesteryl esters rose on the high-CHO diet (44.0 AE 6.6 rising to 49.2 AE 4.6% of total fatty acids, before and after the diet, respectively, P`0.05). These women were judged noncompliant with the diet and further data from them are not reported. In the remaining 21 women, the proportion of linoleic acid in plasma cholesteryl esters declined during 12 weeks on the high-CHO diet (48.6 AE 5.3% to 45.9 AE 5.9% of total fatty acids, before and after the high-CHO diet respectively, P`0.005) ( Table 1 ). In contrast, during the high-MUFA diet the proportion of linoleic acid in cholesteryl esters remained stable (47.0 AE 6.3, 47.0 AE 4.4% of total fatty acids, before and after high-MUFA diet, respectively). Analysis of these data by a general linear model, taking the sequence in which women undertook the diets into account, indicated that the diets differed signi®cantly in relation to change in linoleic acid (P`0.02). No signi®cant change however, was found in the proportion of oleic acid (C18:1) in plasma cholesteryl esters (Table 1) .
Dietary intake
The macronutrient composition of the self-reported habitual diet of these 21 women was 23.3 AE 2.9%, 29.8 AE 6.3%, and 44.7 AE 5.4% energy (%E) from protein, fat and carbohydrate, respectively. Intake of saturated, monounsaturated and polyunsaturated fat comprised 12.8 AE 3.2%E, 11.5 AE 2.4%E and 5.4 AE 1.5%E, respectively. Dietary intake during test diets is given in Table 2 . On the high-CHO diet, intakes of protein and CHO were signi®cantly higher (both P`0.001) than during the high-MUFA diet while intakes of total, polyunsaturated and monounsaturated fat were signi®cantly lower (P`0.001, P`0.01, P`0.01, respectively). Women reported similar energy intakes on each diet (6.2 AE 2.0 and 6.3 AE 1.9 MJad, respectively) but mean intake was higher than the mean level of energy intake that had been prescribed to induce weight loss (4.8 AE 0.7 MJad).
Change in regional body fat distribution in women complying with the high-CHO diet Change in body weight, fat mass and body fat distribution on the test diets is shown in Table 3 . The 21 women lost 1.6 AE 1.6 kg body weight on the high CHO diet and 0.9 AE 1.8 kg on the high MUFA diet. Although slightly more weight appeared to be lost on the high CHO diet, differences were not statistically signi®cant. The women also lost small amounts of fat mass on each diet. While loss of upper body fat was similar on both diets, on the high-CHO diet women lost signi®cantly more fat from the lower body ( 7 0.7 AE 6.6 kg) than they did on the high-MUFA diet ( 7 0.1 AE 0.7 kg). This difference was shown by generalised linear modelling to be signi®cantly related to diet (P`0.02). Signi®cant difference between diets by general linear modelling (P`0.02). 
Diet and regional body fat distribution KZ Walker et al
Change in metabolic parameters and sex hormones At the beginning of the study, the 21 women were hyperglycemic and hyper-insulinemic (mean fasting blood glucose 8.4 AE 2.4 mmolaL, mean fasting insulin 110.5 AE 57.5 pmolaL). The mean value for HbA 1c was 6.8 AE 1.4%. The women also exhibited a typical diabetic dyslipidemia with raised triacylglycerol (mean total cholesterol 5.6 AE 1.1 mmolaL, mean HDL-cholesterol 1.08 AE 0.25 mmolaL, and mean triacylglycerol 2.29 AE 1.51 mmolaL). By general linear modelling, taking the sequence of diets into account, no difference was seen between the two diets in their effects on these metabolic and lipid parameters (data not shown). Change in the sex hormone pro®le during the two diets is given in Table 4 . Neither diet affected levels of oestrone, testosterone, or SHBG. In contrast, DHEAS levels fell after the high-CHO diet (from 3.60 AE 2.86 to 3.02 AE 2.11 mmolaL) but rose after the high-MUFA diet (from 2.93 AE 2.18 to 3.18 AE 2.18 mmolaL) (Figure 1) . By general linear modelling, taking the sequence of diets into account, this difference was found to relate to the difference in diet (P`0.02). Moreover, after adjustment for age, dehydroepiandrosterone sulphate (DHEAS) concentrations after the high-CHO diet were found to be related to levels of lower body fat (r 0.394, P 0.04).
Discussion
This study in post-menopausal women with Type 2 diabetes con®rmed our previous novel ®nding (Walker et al, 1996) that although high-CHO and high-MUFA diets had similar effects on total body fat loss, they differed in their effects on regional fat loss. A high-CHO diet promoted the disproportionate loss of fat from lower body depots (Table  2 ) and resulted in a more centralised pattern of fat distribution.
Twenty-one women following the high-CHO diet showed a signi®cant decline in the proportion of linoleic acid (C18:2) in plasma cholesteryl esters (P`0.02) ( Table  1) . This is consistent with a decrease in reported intake of polyunsaturated fat from 5.4 AE 1.5%E on an habitual diet to an intake of 3.6 AE 1.0%E on the high-CHO diet (P`0.05). As it is well established that the concentration of linoleic acid in the plasma cholesteryl ester fraction is particularly sensitive to dietary linoleic acid intake (Sanders et al, 1994) , these data provide evidence that the women complied with a high-CHO diet, reducing their total fat and linoleic acid intakes. The fact that nine of an original 30 women (30%) from their linoleic acid levels appeared noncompliant with the high-CHO diet, despite continued dietetic advice and support, suggests that this diet is dif®cult for many individuals to follow. Compliance with the high-MUFA diet appears to be less problematic, since the type of fat is changed rather than the total amount. The women in this study all reported acceptance and regular use of the olive oil provided to them throughout the study. In this case, fatty acid content of cholesteryl esters could not be used as a measure of compliance, since the proportion of oleic acid (C18:1) does not closely re¯ect the pattern of dietary intake of monounsaturated fat (Sanders et al, 1994; Ma et al, 1995) .
It is well established that an android pattern of fat deposition is more strongly related to the multiple complications of the insulin resistance syndrome and as a risk factor for Type 2 diabetes and cardiovascular disease than total body fat (Kissebah & Krakower, 1994; Bjo Èrntorp, 1996) . But in women, deposition of fat on the lower body appears to exert some protective effects. A study of 224 pre-and post-menopausal normoglycemic women has shown that deposition of leg fat had a consistent inverse relationship to the presence of an adverse lipid pro®le (Williams et al, 1997) . We also have also shown that women with Type 2 diabetes have signi®cantly less fat deposited on the lower body (hips and legs) than nondiabetic women matched for age and BMI, who are carrying similar amounts of total fat (Stoney et al, 1998) . The studies reported here extend these observations to indicate that lower body fat loss in women with Type 2 diabetes is in¯uenced by the composition of the diet. They con®rm our earlier ®ndings (Walker et al, 1996) and suggest that a high-MUFA diet should be recommended rather than a high-CHO diet to reduce the centralised pattern of adiposity in postmenopausal women with Type 2 diabetes. Signi®cant difference due to type of diet, P`0.02. Figure 1 Change in concentrations of dehydroepiandrosterone sulphate (DHEAS) in serum in 21 postmenopausal women with Type 2 diabetes who followed a low fat, high carbohydrate diet (high-CHO) or a diet high in monounsaturated fat (high-MUFA) for 12 weeks in a randomised crossover design study. Asterisks indicate a signi®cant difference relating to diet (P`0.02) by general linear modelling.
Diet and regional body fat distribution KZ Walker et al While the reason for the effects of high-CHO diets on lower body fat is not known, it is possible that it might involve the action of the sex hormones (Kissebah & Krakawer 1994) . In post-menopausal women, as oestrogen secretion from the ovary declines, the adrenal C 19 androgens DHEA and DHEAS provide the major extra-gonadal sources of oestrogen, by undergoing intracrinal conversion in the stromal cells of adipose tissue and at other sites (Simpson et al, 1997; Tchernof & Poehlman, 1998) . In postmenopausal women, DHEA and DHEAS are also converted peripherally into androstenedione and then into the androgens testostesterone and dihydrotestosterone (Davis & Burger, 1996) . Yet due to the importance of this peripheral conversion in the postmenopausal woman, serum concentrations of oestrone and testosterone may be poor indicators of total androgenic and oestrogenic activity (Labrie et al, 1997) . In line with this, no signi®cant change was observed in serum concentrations of testosterone or oestrone in postmenopausal women following high-CHO or high-MUFA diets (Table 3) . Nevertheless, interestingly, serum concentrations of DHEAS fell on the high-CHO diet, but rose on the high-MUFA diet (P`0.02) (Figure 1 ). Moreover, after correcting for age, DHEAS levels were found to be related to levels of lower-body fat after the high-CHO diet (r 0.394, P 0.04).
SHBG, a circulating steroid-binding protein produced by the liver, that binds both testosterone and oestrogens and therefore affects the bioavailable fraction of these hormones, is lowered by the presence of high serum insulin (Nestler, 1993) . On the high-CHO and high-MUFA diets there was no signi®cant change in plasma insulin concentrations and also no signi®cant change in SHBG (Table 3) .
While its biological effects are as yet not well understood, DHEAS has been suggested to play a favourable role in healthy aging (Ravaglia et al, 1996) . Studies in premenopausal obese women have indicated that while DHEAS levels remain unaltered with caloric restriction (Jakubowicz et al, 1995) , levels of androstenedione, the major metabolite of DHEAS, signi®cantly decrease when dietary fat intake is decreased (Goldin et al, 1994) . This is consistent with our ®nding that DHEAS decreased in women with Type 2 diabetes who followed a high-CHO diet (Table 4) .
Recent studies have indicated that DHEAS may in¯u-ence lipid metabolism through its action on peroxisome proliferator-activator receptor-a (PPAR-a), a nuclear-hormone receptor found in liver (Waxman, 1996) . PPAR-a, which can also be stimulated by long chain fatty acids, including linoleic and oleic acid (Forman et al, 1997; Kliewer et al, 1997) , appears to function as a physiological sensor of lipid levels and plays an important role in modulation of fatty acid b oxidation (Desvergne et al, 1998) . In view of this relationship of DHEAS with lipid metabolism, further studies are needed to further elucidate how DHEAS levels may be altered by diet. Of additional interest are reports that DHEAS is positively correlated with whole body glucose disposal measured by euglycemic clamp in both old and young men and women, a relationship that remains after adjustment for age, sex, body fat, and the waist:hip ratio (Paolisso et al, 1997) . Also ®ndings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), indicate that although DHEAS status is not a major factor in cardiovascular risk in postmenopausal women with Type 2 diabetes, lower levels of DHEAS may be predictive of ischaemic heart disease mortality in this group (Haffner et al, 1996) .
The intriguing possibility that changes in dietary composition may modulate body fat distribution also warrants further investigation. In particular, it is important to elucidate whether the observed effects are related simply to the relative proportions of carbohydrate and fat in the diet or whether different types of fat or carbohydrate elicit independent effects.
